Objective. To measure the effective coverage of a program to control type 2 diabetes.
Introduction
Type 2 diabetes mellitus represents a global health problem, given its rapid increase in the recent decades. In 2010, roughly 221 million individuals worldwide are estimated to have the disease [1] . The occurrence of type 2 diabetes in Mexico has increased roughly 4-fold since 1993, when the prevalence was ,5% [2, 3] , and it is estimated that for 2010 the direct and indirect costs was US$778 427 475 [3] . Because this is a chronic illness, adequate management is a challenge for health services (high costs and complex activities). For example, using the 'chronic care model', elements that should be included are clinical information systems, community resources, decision support, delivery system redesign, healthcare organization and self-management support [4] . Experiences with this model and others more specific to type 2 diabetes, such as 'staged diabetes management', have achieved good outcomes [5, 6] better than conventional medical care.
The performance of healthcare programs for patients with type 2 diabetes is usually evaluated using results of clinical indicators, utilization of specialized services, incidence of complications and use of certain medications [7] . Although these approaches are clinically useful, they do not routinely identify whether gaps are due to problems with infrastructure, healthcare quality or the demand for services, nor do they reflect the complexity of assuring access to care or the limits of medicine [8] that can lead to cause clinical, social and cultural iatrogenesis [9] . Identification of the range of contributors to these gaps is necessary to systematically improve services for all individuals with a healthcare need.
In 2003, the World Health Organization proposed the 'effective coverage' indicator for monitoring health services interventions. Effective coverage is defined as 'the fraction of maximum possible health gain an individual with a healthcare need can expect to receive from the health system' [10] . It incorporates concepts related to need, utilization of services and quality of health care in a single indicator. This conceptualization of quality is complementary to other frameworks for assessment of quality in health care such as Donabedian's measurement framework that includes measures of structure, process and outcomes [11] . The effective coverage can be thought of as a population outcome measure [10] -a somewhat less direct approach to assessing the performance of clinical delivery systems [11] .
Measurement of the quality of health care for patients with type 2 diabetes is widespread [12, 13] , but few studies have attempted to quantify the effective coverage of health services [14] . A prior study focused exclusively on glycemic control, ignoring the other components of this complex chronic disease [4] [5] [6] , and other outcomes such as quality of life [15, 16] . The objective of this study was to calculate the effective coverage of actions taken by a type 2 diabetes management program in Mexico to detect and treat the illness and comorbidity, educate patients and monitor complications.
Methods
The study assessed the diabetes control program of the Secretary of Health of the state of Hidalgo, Mexico. The program began its activities in 1995 and was the first Mexican program to follow Staged Diabetes Management principles [17] . It was implemented gradually in several municipalities, until reaching 42 localities in 2008. Currently, it is part of a program for comprehensive health care in the 30 clinics in the state of Hidalgo. One doctor and one nurse in each clinic are responsible for the program, in addition to other programs such as mental health and maternal -infant care. At the state level, there is a coordinator and a nutriologist who periodically provide training to operations personnel. The actions of the program include activities to prevent diabetes, comprehensive treatment of glycemia and dyslipidemia, as well as medical care for complications associated with type 2 diabetes.
The general sample for the study included the adult population of the state of Hidalgo ( 2.6 million individuals 
Measurement of effective coverage
This was based on the original proposal by Shengelia et al. [10] , with modifications made since the above is focused exclusively on therapeutic actions. The original version performs the calculation using the formula:
where EC is the effective coverage, N ¼ 1 is the true need for receiving healthcare services; if N ¼ 0, then the individual does not have a need for coverage and if 0 , N , 1, then the need is partial. U is the utilization of health service and refers to the probability that the individual with a need will receive the intervention, and Q is the quality, or health gain ratio-the gain provided to the person by an intervention in relation to the maximum possible health gain [10] . In this study, Q was evaluated for each program activity facilitating the exploration of different gaps in delivery. If quality is not considered, then the indicator is equal to the crude coverage or the proportion of users of health services.
Note that for Shengelia quality is synonymous with effectiveness, which is in contrast to the definitions of various authors who include multiple dimensions [20] . A critical analysis identifies effectiveness as a relational and intrinsic property of interventions; relational because it requires specifying the outcome for which an intervention is effective (an intervention could be effective for one outcome while at the same time not effective for another outcome), and intrinsic because an intervention has specific properties (such as physical or chemical) that determine the action [21] . Thus, a health intervention is an action to improve health conditions, with effectiveness being its fundamental property [22] .
Since the program evaluated also includes actions for the detection, education and monitoring of complications, basing it exclusively on concepts related to intervention and effectiveness turned out to be insufficient for a specific evaluation of each medical action. The measurement of health gain requires alternative approaches to measuring health (aside from biomedical outcomes). Therefore, in this study, we identify 'informativeness' as the fundamental property for actions related to detection and the monitoring of complications [23] , while the fundamental property for actions related to education is acquired knowledge and changes in behavior which are ultimately expressed by clinical indicators such as HbA1c [24] . With this approach, we included some elements of process of care improving the evaluation of quality of health care [11] . In summary, to evaluate quality we use clinical goals (effectiveness) recommended by the 'American Association of Clinical Endocrinologists' (AACE) [25] , and other goals to evaluate actions related to detection, education and monitoring of complications. The indicators are defined here and in Table 1 .
Detection of the illness
This action enables implementing clinical actions aimed at controlling the illness and preventing related complications [26] . For the purpose of this study, the number of cases with type 2 diabetes (true health need) was obtained using a meta-analysis of prevalences, and a population extrapolation for those older than 20 years of age (Pop . 20) who were not affiliated with any type of institution that provided health services in the state of Hidalgo. This population is that which theoretically should receive medical care from this type of health institution. The formula used was: type 2 diabetes cases ¼ Prevalence Â Pop . 20. The meta-analysis included data obtained by the ENSA 2000 and the ENSANUT 2006. Only these two surveys were used because they were closest to the timeframe of the program's records. In this case, 
Metabolic control
Maintaining fasting blood glucose and HbA1c below certain critical values helps decrease complications. Likewise, controlling within acceptable ranges triglycerides, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol and blood pressure decreases morbidity and mortality due to cardiovascular disease [27] . The use of metformin 
Education
This is an action to reinforce the therapy [29] , with its greatest impact among individuals with HbA1c . 8% [30] . In this study, it was measured using a summative index of three responses to questions about what is the illness, the treatments that are available and what are the complications of type 2 diabetes. The possible responses were correct/incorrect (Cronbach's alpha 0.87) and generated a score between 0 and 3, corresponding to greater knowledge. In this case, EC e ¼ Q e †U e jN e ¼ 1, where EC e is the effective coverage of education; Q e corresponds to knowledge of diabetes definition, treatment and complications; U e is the assistance to educative session, and N e corresponds to cases of type 2 diabetes who receive care in the program.
Monitoring of complications
Type 2 diabetes increases the risk of decreased vision, retinopathy, blindness, foot infection, amputation of lower extremities, nephropathy and renal insufficiency. In the context of this study, these complications are very relevant because previous failed attempts to measure effective coverage postulated only the inclusion of fasting blood glucose or HbA1c measurements. However, metabolic control can be insufficient to prevent the incidence of these complications. In these cases, EC c ¼ Q c †U c jN c ¼ 1, where EC c is the effective coverage of monitoring complications; Q c is the percentage of evaluations within signs of complications; U c is the evaluation according to clinical guide and N c corresponds to cases of type 2 diabetes who receive care in the program.
Statistical analysis
Data from the three databases were analyzed; the two national surveys were merged through meta-analysis, and the program's registries were analyzed independently. Characteristics were described that were comparable between participants in the ENSA and ENSANUT and the database for program utilization, with measures of central tendency and dispersion. The x 2 test was then used to compare them according to the available sources of information. We estimated 95% confidence intervals (CIs) for proportions. All analyses were performed using the statistical program Stata 11 (Stata Corporation, College Station). Table 2 shows the prevalences of type 2 diabetes obtained from the two surveys as well as the meta-analysis result. Note the increase in prevalences between 2000 and 2006 and the pooled prevalence of 4.95% (95% CI: 4.39, 5.56)-equivalent to 40 387 persons with type 2 diabetes. This same table also shows that the group that was in the program included more women, and that they had a higher average age and a lower educational level. During the period analyzed, the mean number of consultations was 17.8, with a range of 1-74.
Results
The results for each of the components of the effective coverage are found in Table 3 . It can be seen that utilization is 7.1% for the action of detection of type 2 diabetes. Other actions with utilization ,50% are regular measurements of LDL, HDL and HbA1c, and nephropathy prevention. The only actions that exceeded 95% utilization were measurements for fasting glycemia, the regular measurement of blood pressure and monitoring for diabetic foot and diabetic retinopathy. This wide range in utilization is in contrast to the quality observed for the same actions. Among individuals who have diabetes detected, 87.6% of the cases received two or more medical consultations. The lowest quality values observed were for the control of blood glucose and HbA1c. The lesser effective coverage was to nephropathy prevention, glucose control according to HbA1c results among individuals with BMI , 27, and detection of illness. Other medical actions had medium effective coverage, although there was a trend to lower scores when the action was related with a paid by patients.
Discussion
This study presents the first results, using the effective coverage framework, of the performance of a population-based program to control diabetes, identifying and quantifying the primary gaps that need to be overcome if the program is to succeed. The effective coverage was very low for detection of diabetes, but it was also low for several clinical actions that need to be taken among those who are detected, with the most relevant gaps being actions to monitor the incidence of diabetic nephropathy, regular measurements of LDL and HDL cholesterol. Detection of diabetes among general population presents the greatest challenge to overcome. Differences between users and non-users of healthcare services suggest that a first step would be to expand the use of health services.
Medical actions requiring services that have to be purchased by patients were less frequently adhered to. Since affordability gap is more frequent in control actions as measurements of HbA1c and lipids, thus policies to increment insurance of individuals with type 2 diabetes are a good option to increase the coverage. The results suggest one key reason that Mexico is one of the Latin American countries with high incidences of end-stage renal disease due to type 2 diabetes, large numbers of individuals with chronic kidney disease and diabetic patients on peritoneal dialysis [31] . Health system changes will be necessary to prevent such complications.
Two other countries (Colombia and Chile) have reported 'effective coverage' of populations with diabetes with rates of 24.1 and 68.4%, respectively [14] . However, the effective coverage indicator used was fasting blood glucose ,126 md/dl, not a comprehensive indicator of diabetes control [32] . Our study suggests that an effective coverage framework can include a broad range of quality of care indicators (access, process and outcomes) that could facilitate actions to improve diabetes control programs. By defining diabetes control as a population-based effort, effective coverage extends the clinical quality measurement approaches that focus on patients with a diagnosis [7] . The effective coverage indicator as originally proposed is limited in terms of understanding the entire natural history of illness because it focused on an intermediate outcome. We found that it was possible to include accessibility, affordability, unperceived needs, responsiveness and technical quality gaps according to Penchansky and Thomas typology of access [33] . Understanding why these gaps occur needs to be resolved by other types of studies that explicitly investigate those topics. In addition, future experiences that use effective coverage could evaluate a larger number of elements, such as the use of medications and surgical procedures.
The importance of overcoming economic barriers to improve control for individuals with type 2 diabetes in Mexico has been evident in recent studies [2, 3, 34 -36] . For example, the public health insurance program, 'Seguro Popular', enables better control of HbA1c levels, and it was related with greater use of insulin and availability of laboratory tests [37] . This provides the possibility of understanding that adequate control of type 2 diabetes is not only a clinical problem but also occurs in the context of the health system, which can make adequate control among patients easier or more difficult.
These findings should be interpreted carefully, given the inherent limitations in the data used. Most importantly, the data used are electronic records created by clinical physicians, which may result in recording what they should do rather than what they really do during a consultation. The interpretation of results for monitoring of diabetic foot and retinopathy deserves special care. The former requires a physical examination while the latter requires the availability of ophthalmoscopes and expertise on the part of treating physicians. Given that the values observed for quality are high, it is possible that only those related to monitoring diabetic foot are reliable; the available information system only allows the doctor to report whether the evaluation was performed and does not permit verifying the quality of the findings. These limitations are universal in quality studies, thus it is important to assess the validity of data [37] .
In conclusion, use of the effective coverage framework enabled the evaluation of a program to control type 2 diabetes in Mexico. The extensions of the effective coverage indicator in this study illustrate the potential of this approach. Future studies could use the effective coverage to contribute to the continued improvement in the quality of medical care provided to patients with type 2 diabetes mellitus. Development of better data systems may enhance the calculation of composite measures based on the effective coverage framework.
